Pyc Therapeutics Stock Operating Margin
| PYC Stock | 1.40 0.05 3.45% |
PYC Therapeutics fundamentals help investors to digest information that contributes to PYC Therapeutics' financial success or failures. It also enables traders to predict the movement of PYC Stock. The fundamental analysis module provides a way to measure PYC Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to PYC Therapeutics stock.
PYC | Operating Margin |
PYC Therapeutics Company Operating Margin Analysis
PYC Therapeutics' Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current PYC Therapeutics Operating Margin | (1.78) % |
Most of PYC Therapeutics' fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, PYC Therapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Based on the recorded statements, PYC Therapeutics has an Operating Margin of -1.7809%. This is much lower than that of the Biotechnology sector and significantly lower than that of the Health Care industry. The operating margin for all Australia stocks is notably higher than that of the company.
PYC Operating Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses PYC Therapeutics' direct or indirect competition against its Operating Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of PYC Therapeutics could also be used in its relative valuation, which is a method of valuing PYC Therapeutics by comparing valuation metrics of similar companies.PYC Therapeutics is currently under evaluation in operating margin category among its peers.
PYC Fundamentals
| Return On Equity | -0.7 | ||||
| Return On Asset | -0.38 | ||||
| Profit Margin | (1.71) % | ||||
| Operating Margin | (1.78) % | ||||
| Current Valuation | 587.49 M | ||||
| Shares Outstanding | 466.61 M | ||||
| Shares Owned By Insiders | 59.23 % | ||||
| Shares Owned By Institutions | 0.57 % | ||||
| Price To Book | 8.12 X | ||||
| Price To Sales | 29.61 X | ||||
| Revenue | 22.06 M | ||||
| Gross Profit | 15.81 M | ||||
| EBITDA | (38.12 M) | ||||
| Net Income | (37.73 M) | ||||
| Cash And Equivalents | 15.57 M | ||||
| Total Debt | 1.11 M | ||||
| Book Value Per Share | 0.02 X | ||||
| Cash Flow From Operations | (38.59 M) | ||||
| Earnings Per Share | (0.10) X | ||||
| Target Price | 8.75 | ||||
| Beta | 0.6 | ||||
| Market Capitalization | 653.25 M | ||||
| Total Asset | 91.24 M | ||||
| Retained Earnings | (155.89 M) | ||||
| Working Capital | 76.51 M | ||||
| Net Asset | 91.24 M |
About PYC Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze PYC Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of PYC Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of PYC Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for PYC Stock Analysis
When running PYC Therapeutics' price analysis, check to measure PYC Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PYC Therapeutics is operating at the current time. Most of PYC Therapeutics' value examination focuses on studying past and present price action to predict the probability of PYC Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PYC Therapeutics' price. Additionally, you may evaluate how the addition of PYC Therapeutics to your portfolios can decrease your overall portfolio volatility.